TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7040659

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Acupuncture and Control)
Number of subjects: 20
Study: 31287766

Group type: EXPERIMENTAL
Intervention: Growing, Learning, and Living With Autism Group
Number of subjects: 17

Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 17
Study: 28340901

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 0
Study: 25406226

Group type: EXPERIMENTAL
Intervention: Written materials plus nicotine replacement therapy (NRT)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Materials, NRT, and couple-based counseling
Number of subjects: 348
Study: 24942849

Group type: EXPERIMENTAL
Intervention: Automated bolus delivery of 0.2% ropivacaine (4 mL) with PRN boluses (5 mL, lockout 30 min)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Continuous infusion of 0.2% ropivacaine (4 mL/h) with PRN boluses (5 mL, lockout 30 min)
Number of subjects: 101
Study: 17608575

Group type: EXPERIMENTAL
Intervention: Test group (surgical technique without vertical releasing incisions)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (broader flap and vertical releasing incisions)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 15
Study: 15220019

Group type: EXPERIMENTAL
Intervention: Latanoprost, 1 drop in the affected eye QD (evening)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Fixed-combination dorzolamide/timolol, 1 drop in the affected eye BID (morning and evening)
Number of subjects: 229
Study: 10875904

Group type: EXPERIMENTAL
Intervention: Auditory‐motor coordination task with increasing coordination rates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evoked brain responses to acoustic tones and self‐initiated finger movements
Number of subjects: 0
Study: 9353612

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrotherapy (H-Wave machine, pulse width 4 ms, 25-35 V, > or = 2 Hz, 30 min daily for 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrotherapy (after sham treatment)
Number of subjects: 31
Study: 8144852

Group type: EXPERIMENTAL
Intervention: Metyrapone (750 mg orally at 08:00 h on day 1 and at 4 hourly intervals over a 24-h period)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Metyrapone (750 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Hydrocortisone (20 mg tablet)
Number of subjects: 6
Study: 3018023

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of 250 micrograms Cosyntropin (ACTH‐(1‐24))
Number of subjects: 17

Group type: COMPARATOR
Intervention: Bolus injection of 250 micrograms Cosyntropin (ACTH‐(1‐24))
Number of subjects: 17
Study: 31774626

Group type: EXPERIMENTAL
Intervention: Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells (500,000 cells per 20 μL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells
Number of subjects: 0
Study: 30683494

Group type: EXPERIMENTAL
Intervention: Conventional anti-inflammatory treatment plus colchicine for 3 months
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional anti-inflammatory treatment only
Number of subjects: 110
Study: 28818324

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 68

Group type: COMPARATOR
Intervention: Circular external fixator
Number of subjects: 68
Study: 26181174

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (E+P) - 0.625 mg/d conjugated equine estrogens plus 2.5 mg/d medroxyprogesterone acetate
Number of subjects: 27347

Group type: EXPERIMENTAL
Intervention: Estrogen alone - 0.625 mg/d conjugated equine estrogens
Number of subjects: 27347
Study: 24290869

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 29

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 29
Study: 22980306

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 1509
Study: 19414982

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Oral hypoglycemic agent (OHA)
Number of subjects: 29
Study: 17379484

Group type: EXPERIMENTAL
Intervention: Naltrexone (n=52)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Acamprosate (n=56)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo (n=23)
Number of subjects: 131
Study: 14737055

Group type: EXPERIMENTAL
Intervention: G‐CSF at 5 Kg/kg for established febrile neutropenia (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: G‐CSF at 263 Kg/day if ANC was 1500/microl or less (Group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison of Group A and Group B
Number of subjects: 100
Study: 11720296

Group type: EXPERIMENTAL
Intervention: Neuromuscular supervised training
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Self-monitored training
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both training groups (supervised and self-monitored)
Number of subjects: 63
Study: 9427202

Group type: EXPERIMENTAL
Intervention: Initial Corticosteroid Group
Number of subjects: 215

Group type: COMPARATOR
Intervention: No Corticosteroid Group
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Delayed Corticosteroid Group
Number of subjects: 215

Group type: COMPARATOR
Intervention: No/delayed Corticosteroid Group
Number of subjects: 215
Study: 8032072

Group type: EXPERIMENTAL
Intervention: Lower dose (0.4 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Higher dose (0.6 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (without urapidil)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups (including urapidil)
Number of subjects: 30
Study: 3689065

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily) plus aspirin (650 mg four times daily)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo plus aspirin (650 mg four times daily)
Number of subjects: 43
Study: 29482256

Group type: EXPERIMENTAL
Intervention: Risperidone monotherapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole (5mg and 10mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (Risperidone only)
Number of subjects: 60
Study: 27302126

Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma (FFP) 20 mL/kg intravenous
Number of subjects: 54

Group type: COMPARATOR
Intervention: Prothrombin complex concentrate (PCC) 30 IU/kg intravenous
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: FFP
Number of subjects: 54

Group type: COMPARATOR
Intervention: PCC
Number of subjects: 54
Study: 24770624

Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MDMA
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combined MDMA and ethanol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 22846237

Group type: EXPERIMENTAL
Intervention: Male partner's volume per setting for bars and parks or public places
Number of subjects: 1585

Group type: EXPERIMENTAL
Intervention: Male's volume per setting for quiet evening at home
Number of subjects: 1585

Group type: EXPERIMENTAL
Intervention: Female partner's volume for quiet evening at home
Number of subjects: 1585
Study: 21261207

Group type: EXPERIMENTAL
Intervention: Chlorhexidine for cleansing the cord
Number of subjects: 29760
Study: 18940711

Group type: EXPERIMENTAL
Intervention: Tactile touch intervention
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard treatment (a rest hour)
Number of subjects: 44
Study: 16161468

Group type: EXPERIMENTAL
Intervention: Chlorhexamed (0.1% chlorhexidine)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hexoral (0.1% hexetidine)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo-control compound
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Comparison between Chlorhexamed and Hexoral
Number of subjects: 90

Group type: COMPARATOR
Intervention: Comparison between Hexoral and Placebo
Number of subjects: 90
Study: 14561111

Group type: EXPERIMENTAL
Intervention: donepezil
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study: 10833037

Group type: EXPERIMENTAL
Intervention: HIV prevention intervention
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 280
Study: 8890490

Group type: EXPERIMENTAL
Intervention: Direct help (answers)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Indirect help (hints)
Number of subjects: 201
Study: 1617799

Group type: EXPERIMENTAL
Intervention: Arginine alone at 0-30 minutes
Number of subjects: 6

Group type: COMPARATOR
Intervention: Insulin alone at 0 minutes
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Arginine at 0-30 minutes and GHRH at 15 minutes
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Insulin at 0 minutes and arginine at 0-30 minutes
Number of subjects: 6
Study: 6231316

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 0
Study: 29364033

Group type: EXPERIMENTAL
Intervention: Cupping therapy (7-minute treatment with four 2-in cups on trigger points in hamstring)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study: 30290680

Group type: EXPERIMENTAL
Intervention: early intensive BP lowering (systolic target range 140‐160 mm Hg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: guideline‐based BP management (systolic range 160‐180 mm Hg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: not available
Number of subjects: 54
Study: 26868520

Group type: EXPERIMENTAL
Intervention: Intraoral irradiation with 660 nm laser
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Extraoral irradiation with 660 nm laser
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intraoral irradiation with 808 nm laser
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Extraoral irradiation with 808 nm laser
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 60
Study: 24972754

Group type: EXPERIMENTAL
Intervention: Metacognitive training (MCT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Supportive therapy (Control)
Number of subjects: 50
Study: 22853619

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with Traditional Chinese Medicine (TCM) for four cycles, administered every 3 weeks.
Number of subjects: 480

Group type: COMPARATOR
Intervention: Chemotherapy alone (placebo) for four cycles, administered every 3 weeks.
Number of subjects: 480
Study: 20698866

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 44

Group type: COMPARATOR
Intervention: 2% plain lidocaine
Number of subjects: 44
Study: 17971598

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) 30 Gy; 2 Gy daily fractions
Number of subjects: 106

Group type: COMPARATOR
Intervention: No PCI
Number of subjects: 106
Study: 15830302

Group type: EXPERIMENTAL
Intervention: Patient education program (four sessions)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (education after one year)
Number of subjects: 145
Study: 11976209

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10) pretreatment prior to stress
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9696640

Group type: EXPERIMENTAL
Intervention: Acyclovir 400 mg orally twice daily
Number of subjects: 703

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 703
Study: 7928814

Group type: EXPERIMENTAL
Intervention: Cefprozil (20 mg/kg/day bd)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Amoxycillin/clavulanate (13.3 mg/kg/day tid)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 361

Group type: COMPARATOR
Intervention: Amoxycillin/clavulanate
Number of subjects: 361
Study: 2813153

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Acetaminophen 600 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Acetaminophen 600 mg with Codeine 60 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 1096923

Group type: EXPERIMENTAL
Intervention: Azaribine at 200 mg/kg a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azaribine at 125 mg/kg a day
Number of subjects: 0
Study: 31342886

Group type: EXPERIMENTAL
Intervention: Double-fortified salt (DFS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iodized salt (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline serum ferritin (sFt)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline body iron (BI)
Number of subjects: 0
Study: 27655703

Group type: EXPERIMENTAL
Intervention: Surgical or palpation-guided biopsy
Number of subjects: 228

Group type: COMPARATOR
Intervention: CT-guided biopsy
Number of subjects: 228

Group type: COMPARATOR
Intervention: Ongoing chemotherapy
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Biopsy location (lymph nodes/soft tissue)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Biopsy location (lung)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Differential attenuation (HU)
Number of subjects: 228
Study: 26003280

Group type: EXPERIMENTAL
Intervention: HSV‐2 genital reactivation
Number of subjects: 14
Study: 22632171

Group type: EXPERIMENTAL
Intervention: Enhanced MI training program (3.5-day workshop, systematic feedback, and four sessions of supervision)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Enhanced MI training program
Number of subjects: 36
Study: 22071709

Group type: EXPERIMENTAL
Intervention: Recombinant human leptin (rhleptin) infusion for 4 hours
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline (control) infusion for 4 hours
Number of subjects: 16
Study: 19192474

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Medication (Nefazodone)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Psychotherapy (CBASP)
Number of subjects: 429
Study: 16792767

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1% applied twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard moisturizers with SPF 20 sunscreen
Number of subjects: 60
Study: 15327610

Group type: EXPERIMENTAL
Intervention: Laparoscopic uterine nerve ablation (LUNA)
Number of subjects: 123

Group type: COMPARATOR
Intervention: No LUNA
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: LUNA with laparoscopic surgical treatment of endometriosis
Number of subjects: 123

Group type: COMPARATOR
Intervention: No LUNA with laparoscopic surgical treatment of endometriosis
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: LUNA
Number of subjects: 123
Study: 11131930

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg once daily)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Captopril (50 mg three times daily)
Number of subjects: 203
Study: 8937934

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg daily)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Celiprolol (200 mg daily)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ramipril (2.5 mg daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1530170

Group type: COMPARATOR
Intervention: Propofol/N2O (Group II)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Desflurane/N2O (Group I)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Desflurane/O2 (Group IV)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Desflurane/N2O (Group III)
Number of subjects: 91
Study: 4004381

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy with Bilroth II gastrectomy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Encouragement to abstain from alcohol (Control)
Number of subjects: 66
Study: 3479329

Group type: EXPERIMENTAL
Intervention: Adriamycin (ADM) 75 mg/m2 every 3 weeks
Number of subjects: 167

Group type: COMPARATOR
Intervention: 4-epiadriamycin (EPI) 75 mg/m2 every 3 weeks
Number of subjects: 167
Study: 31205121

Group type: EXPERIMENTAL
Intervention: Structured cognitive training (6 weeks)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Unstructured brain jogging (6 weeks)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 105
Study: 28403472

Group type: EXPERIMENTAL
Intervention: Emotion regulation treatment combined with standard cognitive-behavioral smoking cessation (ERT + CBT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Health and lifestyle plus standard smoking cessation active control (HLS + CBT)
Number of subjects: 70
Study: 26577919

Group type: EXPERIMENTAL
Intervention: 33 °C
Number of subjects: 939

Group type: COMPARATOR
Intervention: 36 °C
Number of subjects: 939
Study: 23785038

Group type: EXPERIMENTAL
Intervention: Individualized reading instruction for 1, 2, or 3 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treated control condition intervention focused on mathematics
Number of subjects: 0
Study: 21513917

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) intervention
Number of subjects: 106

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 106
Study: 18498953

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 322
Study: 16291802

Group type: EXPERIMENTAL
Intervention: fMRI signal changes in the posterior parietal cortex (PPC) during memory of target locations; no specific dosage or duration mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory of two sequentially flashed targets presented in either the same or different visual hemifields; no specific dosage or duration mentioned.
Number of subjects: 0
Study: 12702116

Group type: EXPERIMENTAL
Intervention: Test abutments with varying surface roughness
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (original abutments)
Number of subjects: 9
Study: 10986206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 792

Group type: COMPARATOR
Intervention: Ranitidine 150 mg
Number of subjects: 792

Group type: COMPARATOR
Intervention: Omeprazole 10 mg
Number of subjects: 792

Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 792
Study: 8715781

Group type: EXPERIMENTAL
Intervention: Soothing music played during dinner for two weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Swedish tunes from the 1920s and 1930s played during dinner for two weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pop music played during dinner for two weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: No music for one week prior to music interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control period of two weeks after music interventions
Number of subjects: 0
Study: 1426317

Group type: EXPERIMENTAL
Intervention: Human recombinant GH (24 IU)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 2412829

Group type: EXPERIMENTAL
Intervention: Fibrin adhesive (Tisseel)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dexon sutures
Number of subjects: 16
Study: 31473392

Group type: EXPERIMENTAL
Intervention: Real ionization air purification
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham purification (control)
Number of subjects: 44
Study: 29193576

Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control
Number of subjects: 312
Study: 27566635

Group type: EXPERIMENTAL
Intervention: NIRF imaging laparoscopic cholecystectomy (NIRF‐LC)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 308
Study: 24999076

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment aiming for a target systolic blood pressure of 120-140 mmHg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conservative antihypertensive treatment as recommended by guidelines for 7 days
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conservative antihypertensive treatment
Number of subjects: 200
Study: 22859825

Group type: EXPERIMENTAL
Intervention: 3 doses of quadrivalent human papillomavirus vaccine (QHPV)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 4 doses of quadrivalent human papillomavirus vaccine (QHPV)
Number of subjects: 100
Study: 20392870

Group type: EXPERIMENTAL
Intervention: PTH 1‐34
Number of subjects: 12

Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 12
Study: 18514933

Group type: EXPERIMENTAL
Intervention: Yoga treatment (YT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard medical therapy (MT)
Number of subjects: 19
Study: 16200819

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (200 microg once daily)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Levocabastine hydrochloride (200 microg twice daily)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Disodium cromoglycate (5.6 mg 4 times daily)
Number of subjects: 123
Study: 12109768

Group type: EXPERIMENTAL
Intervention: Central concepts in narrative texts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peripheral concepts in script-based texts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Central concepts in script-based texts
Number of subjects: 0
Study: 9475262

Group type: EXPERIMENTAL
Intervention: molsidomine (6 mg/h)
Number of subjects: 15

Group type: COMPARATOR
Intervention: isosorbide-5-mononitrate (3.75 mg/h)
Number of subjects: 15
Study: 8574314

Group type: EXPERIMENTAL
Intervention: Intensive therapy aimed at increasing vocal and respiratory effort (VR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intensive therapy aimed at increasing respiratory effort (R)
Number of subjects: 22
Study: 2677866

Group type: EXPERIMENTAL
Intervention: Hemostatic sutures
Number of subjects: 200

Group type: COMPARATOR
Intervention: Monsel's solution and vaginal pack (non-suture technique)
Number of subjects: 200